HANGZHOU TIGERMED CO. H 1 (5HZ1) — Cash Flow Reinvestment Rate
HANGZHOU TIGERMED CO. H 1 (5HZ1) has a Cash Flow Reinvestment Rate of 1.01x as of December 2025, reinvesting €1.13 Billion (capex €214.37 Million plus investments €914.13 Million) from operating cash flow of €1.12 Billion. Check 5HZ1 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
HANGZHOU TIGERMED CO. H 1 Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for HANGZHOU TIGERMED CO. H 1 across 5 annual periods. Explore 5HZ1 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for HANGZHOU TIGERMED CO. H 1 (2021–2025)
Year-by-year capital reinvestment analysis for HANGZHOU TIGERMED CO. H 1. For live market cap and broader valuation context, see 5HZ1 company net worth.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.01x | €1.13 Billion | €1.12 Billion | €214.37 Million | ▼ -74.7% |
| 2024 | 3.99x | €4.38 Billion | €1.10 Billion | €356.55 Million | ▲ +271.0% |
| 2023 | 1.08x | €1.24 Billion | €1.15 Billion | €313.76 Million | ▼ -34.2% |
| 2022 | 1.64x | €2.22 Billion | €1.36 Billion | €448.60 Million | ▼ -6.6% |
| 2021 | 1.75x | €2.49 Billion | €1.42 Billion | €368.62 Million | — |